Latest Developments in Global Immunoassay Gamma Counters Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Immunoassay Gamma Counters Market

  • Pharmaceutical
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2023, Hidex Oy, a Finland-based manufacturer of laboratory instrumentation, introduced an upgraded version of its automated gamma counter, featuring enhanced software integration and multi-detector configurations. Designed for high-throughput environments, the system supports improved assay flexibility and data accuracy, reinforcing Hidex’s position as a key innovator in radioactivity-based diagnostic instrumentation and supporting laboratories in achieving streamlined, efficient diagnostic workflows
  • In March 2023, PerkinElmer Inc. launched a next-generation gamma counter system tailored for advanced clinical diagnostics and life sciences research. This newly developed platform incorporates faster sample processing, reduced background interference, and broader compatibility with radioisotope-based assays. The release underscores PerkinElmer’s strategic commitment to developing precision diagnostic tools aligned with the growing demand for accurate biomarker detection across global healthcare systems
  • In March 2023, Beckman Coulter Life Sciences announced the expansion of its gamma counting solutions into emerging markets through localized partnerships in Southeast Asia and Latin America. This move is aimed at increasing accessibility to high-performance gamma counters in underserved regions by offering affordable, compact models along with localized support and training. The initiative highlights the company’s focus on global health equity and infrastructure development in diagnostic testing
  • In February 2023, Capintec, Inc., a leading supplier of nuclear medicine instrumentation, revealed a collaboration with several U.S.-based healthcare institutions to implement its latest gamma counter systems in nuclear endocrinology testing. The partnership focuses on improving workflow efficiency and diagnostic accuracy in hormone analysis, demonstrating Capintec’s efforts to integrate its systems into clinical practice and support disease management through radioimmunoassay technology
  • In January 2023, LabLogic Systems Ltd. launched a new version of its Wizard3 gamma counter, featuring enhanced user interface design, cloud data storage compatibility, and automated quality control routines. Introduced at a major European life sciences trade event, the product aims to improve data security and remote accessibility for laboratory teams, reflecting the rising demand for digitized and compliant diagnostic technologies in both academic and clinical research settings